These factors work together to help support weight loss
OXM has a dual role as an agonist for GLP1R (glucagon-like peptide-1 receptor) and GCGR (glucagon receptor), leading to decreased appetite and increased human energy expenditure
Clinically, NAD supports: Cellular repair and recovery Improved mitochondrial ATP production Reduced oxidative stress and inflammation Enhanced vascular responsiveness and microcirculation Neurologic, muscular, and metabolic tissue health By optimizing the cellular environment, NAD IV therapy helps the bodys natural healing and recovery processes function at a higher levelparticularly in aging tissue, post-inflammatory states, neurologic stress, and high-performance demands
[9] [12] [17] Developed by Eli Lilly and Company, tirzepatide was approved for treatment of diabetes in the US in May 2022, [9] [12] in the European Union in September 2022, [11] in Canada in November 2022, [18] and in Australia in December 2022
Consult your healthcare provider before combining this supplement with other medications or supplements